This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Learn when to mix SP 500 and bond funds in retirement to balance risk and growth. This brief guide covers practical timing rules to help you stay on track.
28,542 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Patience and a long time horizon are the most powerful tools in any investor’s kit. This guide explains why waiting f...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...
Investors watched spacemobile stock crushed thursday move sharply as AT&T, Verizon, and T-Mobile signaled a bold sate...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Active ETFs are reshaping how people think about investing. This article explains what they are, when they can beat p...
Two iconic beverage players, Coca-Cola and PepsiCo, face different growth paths as 2026 approaches. This article brea...